Search Results - M. V. Miroshnikov
- Showing 1 - 6 results of 6
-
1
Assessment of functional safety of blood forming organs in research of toxicological properties of medicinal products (Review). Part 1. Features of the hematopoietic organs of labo... by N. M. Faustova, A. E. Saloponova, M. V. Miroshnikov, M. N. Makarova, V. G. Makarov
Published 2025-07-01
Article -
2
-
3
-
4
Cardiovascular Safety Assessment of Medicines in Preclinical <i>In vivo</i> Studies: A Review by K. T. Sultanova, M. V. Miroshnikov, A. Yu. Borodina, E. V. Simonova, Zh. Yu. Ustenko, E. V. Mazukina, K. L. Kryshen, A. A. Matichin, M. N. Makarova, V. G. Makarov
Published 2022-03-01
Article -
5
Study of the Safety and Toxicokinetic Parameters of the Drug Eladis® in Preclinical Trials with Repeated Administration by A. A. Matichin, M. V. Miroshnikov, A. A. Matichina, V. M. Kosman, M. V. Karlina, E. M. Petrova, A. A. Globenko, E. A. Jain, A. V. Kapashin, A. L. Vladykin, A. S. Kolosov, M. A. Pasko
Published 2025-04-01
Article -
6
Interpretation of toxicological research data in establishing the no observed adverse effect level (NOAEL) for medicinal products by K. L. Kryshen, Ya. A. Gushchin, N. M. Faustova, S. V. Gushchina, Zh. Yu. Ustenko, A. E. Katelnikova, K. T. Sultanova, A. A. Matichin, V. A. Vavilova, Ya. G. Murazov, M. V. Miroshnikov, M. A. Kovaleva, D. V. Shubin, V. G. Makarov, M. N. Makarova
Published 2025-07-01
Article